JPRN-UMIN000012256已完成2 期
Pase II study of neoadjuvant chemotherapy with Docetaxel, Carboplatin, and Trastuzumab for operable Her2-positive breast cancer patients. - KBC-SG 1201
Kyushu Breast Cancer Study Group0 个研究点目标入组 30 人开始时间: 2013年11月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Clinically inadequate heart function at the registration and/or with past history. 2.Severe uncontrolled complications (Uncontrolled DM, HT, liver dysfunction, renal dysfunction, infection mental manifestation). 3.Women during pregnancy or shortly after childbirth. 4.Double active cancer (in less than 5 years after the last treatment). 5.Women with bilateral breast cancer (synchronous or heterochronous). 6.Women with pulmonary fibrosis and/or interstitial pneumonia. 7.Patients with allergy to the medicines in this protocol treatment. 8.Patients judged inappropriate for this study by the physicians.
研究者
相似试验
已完成
不适用
A phase 2 study of Neoadjuvant chemotherapy in Docetaxel plus Cyclophosphamide plus Trastuzumab with Operable HER2 Positive breast cancerbreast cancerJPRN-UMIN000013263Kyoto Prefectural University of Medicine40
已完成
不适用
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
已完成
2 期
A Phase II study of Neoadjuvant chemotherapy in Docetaxel and Cyclophosphamide(TC therapy) with Operable HER2 Negative breast cancerbreast cancerJPRN-UMIN000013261Kyoto Prefectural University of Medicine50
进行中（未招募）
1 期
Phase II Study of Neoadjuvant Chemotherapy With Dose-Dense Paclitaxel In Association With Carboplatin followed by Radical Surgery for Locally Advanced Cervical Cancer (FIGO stage IB2- IIIA) Patients.EUCTR2016-003294-18-ITFONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI46
招募中
2 期
Phase II Trial of neoadjuvant chemotherapy with docetaxel, cisplatin and 5-FU for advanced esophageal canceresophageal cancerJPRN-UMIN000007408Second Department of Surgery, Wakayama Medical University40